A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
List view / Grid view
Filter the results
The ISCT is objecting linking the benefits of cellular immunotherapy with third party offerings of T-cell banking for future therapeutics.
New study shows that a subset of follicular helper T cells contributes to the hyposialylation of autoantibodies in rheumatoid arthritis.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
New study shows the ability of CD8+ cytotoxic T cells to penetrate a large target, which opens avenues to destroy solid cancers.
Scientists have discovered a way to improve immune-based treatments by modulating T cells.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
Scientists from LifeArc, an independent medical research charity in the UK, explain how they’re using the latest imaging technologies to progress drug discovery campaigns and identify the most promising candidates for antibody-based therapies.
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
The SCIB2 vaccine is to to be administered using new nanoparticle formulation in planned Phase 1/2 clinical trial.
23 May 2019 | By Sartorius
Join us as we discuss the promises and pitfalls associated with developing individualised antigen-specific T-cell therapy products for clinical use.
Scientists have detailed the role of a key controlling factor in the transformation of B-cells into antibody-secreting cells.